Elevated PSA. Per an EPIC note the patient has newly diagnosed Gleason 6 cancer single core. TRUS-prostate biopsy pathology 2/9/16:L base: benignL mid: benignL apex Focal ASAPL lat base: No specimen presentL lat mid: benignL lat apex: prostate adenocarcinoma Gl 3+3=6, 20% of specimen, involving 2 of 3 core segments, with cores measuring 2, 5, and 9 mmR base: benignR mid: benignR apex: benignR lat base: benignR lat mid: benignR lat apex benign PELVIS:PROSTATE:Prostate Size: 3.3 x 4.4 x 3.1 cmPeripheral Zone: The peripheral zone is diffusely heterogeneously low on T2-weighted imaging with linear bands of low signal, likely representing diffuse prostatitis changes. This limits evaluation for underlying lesions.No dominant lesion is identified.Central Gland: The intra-prostatic proximal urethra is prominent without significant nodularity of the transition zone.Seminal Vesicles: No evidence of seminal vesicle invasion.Extracapsular Extension: No evidence of extracapsular extension.BLADDER: No significant abnormality noted.LYMPH NODES: Multiple prominent pelvic lymph nodes are nonspecific in the setting of sarcoidosis.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Evaluation is limited due to diffuse T2-weighted signal hypointensity in the peripheral zone which may be related to prostatitis. No superimposed dominant lesion is identified.2.Multiple prominent pelvic lymph nodes are nonspecific setting of sarcoidosis.